Phase I/II trial of carboplatin, TS-1, and concurrent radiation therapy in elderly patients with locally advanced non-small cell lung cancer.
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 22 Jun 2017
At a glance
- Drugs Carboplatin (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 20 Jun 2017 Status changed from recruiting to active, no longer recruiting.
- 07 Jun 2016 Results of the phase I portion of the study were presented at the 52nd Annual Meeting of the American Society of Clinical Oncology (2016).
- 21 Jun 2011 New trial record